KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Receivables: 2009-2024

Historic Change in Receivables for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to $21.1 million.

  • Jazz Pharmaceuticals' Change in Receivables rose 129.13% to $51.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year decrease of 59.36%. This contributed to the annual value of $21.1 million for FY2024, which is 59.30% down from last year.
  • As of FY2024, Jazz Pharmaceuticals' Change in Receivables stood at $21.1 million, which was down 59.30% from $51.9 million recorded in FY2023.
  • In the past 5 years, Jazz Pharmaceuticals' Change in Receivables ranged from a high of $92.7 million in FY2021 and a low of $21.1 million during FY2024.
  • Over the past 3 years, Jazz Pharmaceuticals' median Change in Receivables value was $51.9 million (recorded in 2023), while the average stood at $54.4 million.
  • In the last 5 years, Jazz Pharmaceuticals' Change in Receivables skyrocketed by 139.95% in 2021 and then crashed by 59.30% in 2024.
  • Yearly analysis of 5 years shows Jazz Pharmaceuticals' Change in Receivables stood at $38.6 million in 2020, then soared by 139.95% to $92.7 million in 2021, then dropped by 2.80% to $90.1 million in 2022, then crashed by 42.44% to $51.9 million in 2023, then crashed by 59.30% to $21.1 million in 2024.